Regulation 5 Prohibition on administration of beta-agonists or hormonal substances
Subject to paragraph (2), a person shall not administer or knowingly cause or permit to be administered to any animal any—
substance listed in Annexes II or III of Council Directive 96/22; or
any product which is, or which contains a substance listed in either of those Annexes.
The prohibition in paragraph (1) shall not apply to the administration of a compliant veterinary medicinal product —
containing testosterone, progesterone or a derivative of these substances which readily yields the parent compound on hydrolysis after absorption at the site of application, if that product is administered in accordance with regulation 26;
containing allyl trenbolone or a beta-agonist, if that product is administered in accordance with regulation 27; or
having oestrogenic action (but not containing oestradiol 17b or its ester-like derivatives), androgenic action or gestagenic action, if that product is administered in accordance with regulation 28.
Paragraph (2), “compliant veterinary medicinal product” means a veterinary medicinal product which complies with the requirements of regulation 25.